Zur Rose Group AG reported preliminary revenue results for the year ended December 31, 2018. The Group successfully implemented its growth targets in the 2018 financial year with revenue of CHF 1,207.2 million compared to CHF 982.921 million in 2017.

For the quarter, the company's revenue was CHF 317,947,000 against CHF 271,294,000 a year ago.

Management continues to expect sales growth of over 20% in local currency for 2018 and break-even on EBITDA level, adjusted for exceptional charges and PromoFarma.